The global DPT Vaccines market size was valued at USD 5338.1 million in 2022 and is forecast to a readjusted size of USD 6722.7 million by 2029 with a CAGR of 3.3% during review period.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc. The top 2 companies hold a share over 90%. Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report is a detailed and comprehensive analysis for global DPT Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Age. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global DPT Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market size and forecasts, by Type and by Age, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2018-2029
Global DPT Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DPT Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DPT Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
DTaP
Tdap
DTwP
12 Months Below
12 Months Above
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe DPT Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales, revenue and global market share of DPT Vaccines from 2018 to 2023.
Chapter 3, the DPT Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and age, with sales market share and growth rate by type, age, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and DPT Vaccines market forecast, by regions, type and age, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccines.
Chapter 14 and 15, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of DPT Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DPT Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 DTaP
1.3.3 Tdap
1.3.4 DTwP
1.4 Market Analysis by Age
1.4.1 Overview: Global DPT Vaccines Consumption Value by Age: 2018 Versus 2022 Versus 2029
1.4.2 12 Months Below
1.4.3 12 Months Above
1.5 Global DPT Vaccines Market Size & Forecast
1.5.1 Global DPT Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global DPT Vaccines Sales Quantity (2018-2029)
1.5.3 Global DPT Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur DPT Vaccines Product and Services
2.1.4 Sanofi Pasteur DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Vaccines Product and Services
2.2.4 GSK DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
2.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics DPT Vaccines Product and Services
2.4.4 KM Biologics DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 KM Biologics Recent Developments/Updates
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products DPT Vaccines Product and Services
2.5.4 Wuhan Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology DPT Vaccines Product and Services
2.6.4 Walvax Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Walvax Biotechnology Recent Developments/Updates
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products DPT Vaccines Product and Services
2.7.4 Chengdu Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology DPT Vaccines Product and Services
2.8.4 Minhai Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Minhai Biotechnology Recent Developments/Updates
3 Competitive Environment: DPT Vaccines by Manufacturer
3.1 Global DPT Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global DPT Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global DPT Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of DPT Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 DPT Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 DPT Vaccines Manufacturer Market Share in 2022
3.5 DPT Vaccines Market: Overall Company Footprint Analysis
3.5.1 DPT Vaccines Market: Region Footprint
3.5.2 DPT Vaccines Market: Company Product Type Footprint
3.5.3 DPT Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global DPT Vaccines Market Size by Region
4.1.1 Global DPT Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global DPT Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global DPT Vaccines Average Price by Region (2018-2029)
4.2 North America DPT Vaccines Consumption Value (2018-2029)
4.3 Europe DPT Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific DPT Vaccines Consumption Value (2018-2029)
4.5 South America DPT Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa DPT Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global DPT Vaccines Sales Quantity by Type (2018-2029)
5.2 Global DPT Vaccines Consumption Value by Type (2018-2029)
5.3 Global DPT Vaccines Average Price by Type (2018-2029)
6 Market Segment by Age
6.1 Global DPT Vaccines Sales Quantity by Age (2018-2029)
6.2 Global DPT Vaccines Consumption Value by Age (2018-2029)
6.3 Global DPT Vaccines Average Price by Age (2018-2029)
7 North America
7.1 North America DPT Vaccines Sales Quantity by Type (2018-2029)
7.2 North America DPT Vaccines Sales Quantity by Age (2018-2029)
7.3 North America DPT Vaccines Market Size by Country
7.3.1 North America DPT Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America DPT Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe DPT Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe DPT Vaccines Sales Quantity by Age (2018-2029)
8.3 Europe DPT Vaccines Market Size by Country
8.3.1 Europe DPT Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe DPT Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific DPT Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific DPT Vaccines Sales Quantity by Age (2018-2029)
9.3 Asia-Pacific DPT Vaccines Market Size by Region
9.3.1 Asia-Pacific DPT Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific DPT Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America DPT Vaccines Sales Quantity by Type (2018-2029)
10.2 South America DPT Vaccines Sales Quantity by Age (2018-2029)
10.3 South America DPT Vaccines Market Size by Country
10.3.1 South America DPT Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America DPT Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa DPT Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa DPT Vaccines Sales Quantity by Age (2018-2029)
11.3 Middle East & Africa DPT Vaccines Market Size by Country
11.3.1 Middle East & Africa DPT Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa DPT Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 DPT Vaccines Market Drivers
12.2 DPT Vaccines Market Restraints
12.3 DPT Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of DPT Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of DPT Vaccines
13.3 DPT Vaccines Production Process
13.4 DPT Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DPT Vaccines Typical Distributors
14.3 DPT Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global DPT Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global DPT Vaccines Consumption Value by Age, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur DPT Vaccines Product and Services
Table 6. Sanofi Pasteur DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK DPT Vaccines Product and Services
Table 11. GSK DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Mitsubishi Tanabe Pharma Major Business
Table 15. Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
Table 16. Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 18. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 19. KM Biologics Major Business
Table 20. KM Biologics DPT Vaccines Product and Services
Table 21. KM Biologics DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. KM Biologics Recent Developments/Updates
Table 23. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 24. Wuhan Institute of Biological Products Major Business
Table 25. Wuhan Institute of Biological Products DPT Vaccines Product and Services
Table 26. Wuhan Institute of Biological Products DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Wuhan Institute of Biological Products Recent Developments/Updates
Table 28. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 29. Walvax Biotechnology Major Business
Table 30. Walvax Biotechnology DPT Vaccines Product and Services
Table 31. Walvax Biotechnology DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Walvax Biotechnology Recent Developments/Updates
Table 33. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 34. Chengdu Institute of Biological Products Major Business
Table 35. Chengdu Institute of Biological Products DPT Vaccines Product and Services
Table 36. Chengdu Institute of Biological Products DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Chengdu Institute of Biological Products Recent Developments/Updates
Table 38. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Minhai Biotechnology Major Business
Table 40. Minhai Biotechnology DPT Vaccines Product and Services
Table 41. Minhai Biotechnology DPT Vaccines Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Minhai Biotechnology Recent Developments/Updates
Table 43. Global DPT Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 44. Global DPT Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global DPT Vaccines Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 46. Market Position of Manufacturers in DPT Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and DPT Vaccines Production Site of Key Manufacturer
Table 48. DPT Vaccines Market: Company Product Type Footprint
Table 49. DPT Vaccines Market: Company Product Application Footprint
Table 50. DPT Vaccines New Market Entrants and Barriers to Market Entry
Table 51. DPT Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 53. Global DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 54. Global DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global DPT Vaccines Average Price by Region (2018-2023) & (US$/Dose)
Table 57. Global DPT Vaccines Average Price by Region (2024-2029) & (US$/Dose)
Table 58. Global DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 59. Global DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 60. Global DPT Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global DPT Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global DPT Vaccines Average Price by Type (2018-2023) & (US$/Dose)
Table 63. Global DPT Vaccines Average Price by Type (2024-2029) & (US$/Dose)
Table 64. Global DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 65. Global DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 66. Global DPT Vaccines Consumption Value by Age (2018-2023) & (USD Million)
Table 67. Global DPT Vaccines Consumption Value by Age (2024-2029) & (USD Million)
Table 68. Global DPT Vaccines Average Price by Age (2018-2023) & (US$/Dose)
Table 69. Global DPT Vaccines Average Price by Age (2024-2029) & (US$/Dose)
Table 70. North America DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 71. North America DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 72. North America DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 73. North America DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 74. North America DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 75. North America DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 76. North America DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 79. Europe DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 80. Europe DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 81. Europe DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 82. Europe DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 83. Europe DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 84. Europe DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 87. Asia-Pacific DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 88. Asia-Pacific DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 89. Asia-Pacific DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 90. Asia-Pacific DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 91. Asia-Pacific DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 92. Asia-Pacific DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 95. South America DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 96. South America DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 97. South America DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 98. South America DPT Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 99. South America DPT Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 100. South America DPT Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America DPT Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa DPT Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 103. Middle East & Africa DPT Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 104. Middle East & Africa DPT Vaccines Sales Quantity by Age (2018-2023) & (M Doses)
Table 105. Middle East & Africa DPT Vaccines Sales Quantity by Age (2024-2029) & (M Doses)
Table 106. Middle East & Africa DPT Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 107. Middle East & Africa DPT Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 108. Middle East & Africa DPT Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa DPT Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 110. DPT Vaccines Raw Material
Table 111. Key Manufacturers of DPT Vaccines Raw Materials
Table 112. DPT Vaccines Typical Distributors
Table 113. DPT Vaccines Typical Customers
List of Figures
Figure 1. DPT Vaccines Picture
Figure 2. Global DPT Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global DPT Vaccines Consumption Value Market Share by Type in 2022
Figure 4. DTaP Examples
Figure 5. Tdap Examples
Figure 6. DTwP Examples
Figure 7. Global DPT Vaccines Consumption Value by Age, (USD Million), 2018 & 2022 & 2029
Figure 8. Global DPT Vaccines Consumption Value Market Share by Age in 2022
Figure 9. 12 Months Below Examples
Figure 10. 12 Months Above Examples
Figure 11. Global DPT Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global DPT Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global DPT Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 14. Global DPT Vaccines Average Price (2018-2029) & (US$/Dose)
Figure 15. Global DPT Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global DPT Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of DPT Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 DPT Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 DPT Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa DPT Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global DPT Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global DPT Vaccines Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 31. Global DPT Vaccines Consumption Value Market Share by Age (2018-2029)
Figure 32. Global DPT Vaccines Average Price by Age (2018-2029) & (US$/Dose)
Figure 33. North America DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 35. North America DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 42. Europe DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 51. Asia-Pacific DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 61. South America DPT Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America DPT Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Age (2018-2029)
Figure 67. Middle East & Africa DPT Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa DPT Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa DPT Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. DPT Vaccines Market Drivers
Figure 74. DPT Vaccines Market Restraints
Figure 75. DPT Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of DPT Vaccines in 2022
Figure 78. Manufacturing Process Analysis of DPT Vaccines
Figure 79. DPT Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
